Zim Laboratories Limited Market Cap ($75.05 Million)
Market Cap & Net Worth: Zim Laboratories Limited (ZIMLAB)
Zim Laboratories Limited market cap. Zim Laboratories Limited (NSE:ZIMLAB) has a market capitalization of $75.05 Million (Rs6.94 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #20120 globally and #1106 in its home market, demonstrating a 12.39% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zim Laboratories Limited's stock price Rs142.39 by its total outstanding shares 48735814 (48.74 Million). Also see ZIMLAB operating cash flow for how efficiently the company converts equity into cash flow.
Zim Laboratories Limited Market Cap History (2022–2026)
Zim Laboratories Limited market cap history from 2022 to 2026. Data shows growth from $51.23 Million to $75.05 Million (6.25% CAGR). Check ZIMLAB stock price for real-time trading data and today's change.
Zim Laboratories Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zim Laboratories Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Zim Laboratories Limited (ZIMLAB) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
Zim Laboratories Limited's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.31x
Zim Laboratories Limited's market cap is 0.31 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $51.23 Million | $3.31 Billion | $145.50 Million | 0.02x | 0.35x |
| 2023 | $60.80 Million | $3.99 Billion | $244.34 Million | 0.02x | 0.25x |
| 2024 | $56.67 Million | $3.68 Billion | $172.46 Million | 0.02x | 0.33x |
| 2025 | $38.03 Million | $3.74 Billion | $121.65 Million | 0.01x | 0.31x |
Competitor Companies of ZIMLAB by Market Capitalization
Companies near Zim Laboratories Limited in the global market cap rankings as of November 4, 2026. Also see Zim Laboratories Limited assets under control for a full breakdown of the balance sheet.
Key companies related to Zim Laboratories Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Zim Laboratories Limited (2022–2026)
Market capitalization of Zim Laboratories Limited from 2022 to today. Between 2022 and today, Zim Laboratories Limited's market cap moved from $51.23 Million to $ 75.05 Million, with a yearly change of 6.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs75.05 Million | +97.35% |
| 2025 | Rs38.03 Million | -32.90% |
| 2024 | Rs56.67 Million | -6.79% |
| 2023 | Rs60.80 Million | +18.67% |
| 2022 | Rs51.23 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Zim Laboratories Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $75.05 Million USD |
| MoneyControl | $75.05 Million USD |
| MarketWatch | $75.05 Million USD |
| marketcap.company | $75.05 Million USD |
| Reuters | $75.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zim Laboratories Limited
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers the… Read more